National Vision Holdings, Inc. — Form 10-Q Summary
Period: Fiscal second quarter and six months ended July 2, 2022 (13 and 26 weeks, respectively), compared with periods ended July 3, 2021. The request metadata says 2021 Q2, but the filing is for 2022 Q2. Amounts below are in millions unless noted.
Business context and reporting period
National Vision is a U.S. value optical retailer offering eyewear, contact lenses and eye care through owned, host and managed-store brands, plus e-commerce. It operated 1,314 locations at quarter-end, up from 1,249 a year earlier. Reportable segments are Owned & Host and Legacy.
Financial performance
| Metric | Q2 2022 | Q2 2021 | Six months 2022 | Six months 2021 |
|---|---|---|---|---|
| Net revenue | $509.6 | $549.5 | $1,037.3 | $1,083.7 |
| Income from operations | $18.4 | $54.8 | $55.7 | $116.3 |
| Net income | $9.7 | $37.6 | $39.9 | $81.0 |
| Diluted EPS | $0.12 | $0.42 | $0.47 | $0.89 |
| Adjusted EBITDA (non-GAAP) | $51.2 | $87.7 | $119.7 | $177.1 |
| Adjusted EBITDA margin (non-GAAP) | 10.0% | 16.0% | 11.5% | 16.3% |
Q2 costs applicable to revenue were 46.0% of revenue, versus 42.9%; SG&A was 44.7%, versus 42.6%; operating margin was 3.6%, versus 10.0%; and net margin was 1.9%, versus 6.8%. For the first half, operating margin was 5.4% versus 10.7%, and net margin was 3.8% versus 7.5%.
- Cash flow: First-half operating cash flow was $88.0, down from $189.8. Investing outflow was $55.7, including $55.7 of property and equipment purchases; financing outflow was $83.6. Cash, cash equivalents and restricted cash ended at $255.6, down $51.3 from year-end.
- Liquidity and debt: Cash and cash equivalents were $254.4. Revolver availability was $293.6, including $6.4 of outstanding letters of credit. Debt included $402.5 principal of 2.50% convertible notes due 2025 and a $150.0 term loan due 2024; finance lease obligations were $24.0. The company reported compliance with debt covenants.
- Balance sheet: Current assets were $480.5 and current liabilities $353.8. Inventory was $129.5, compared with $123.7 at fiscal year-end.
Material changes versus prior comparable periods
- Q2 revenue declined 7.3%; first-half revenue declined 4.3%. Adjusted comparable-store sales fell 12.4% in Q2 and 9.6% for the first half, driven mainly by fewer customer transactions and, to a lesser extent, lower average ticket.
- Q2 net income fell to $9.7 from $37.6. Management cited weaker sales, lower eyeglass mix and margins, increased optometrist-related costs, and payroll and occupancy pressures. First-half operating cash flow was also materially lower, reflecting lower earnings and less favorable working-capital movements.
- Q2 and first-half asset impairment charges were $3.5 and $3.9, respectively, versus $0.5 and $1.5 in the prior-year periods; charges related principally to stores with lower-than-projected sales.
- The company repurchased approximately 2.7 million shares for $80.0 during the first half. At July 2, approximately $50.0 remained under its authorization.
- Net interest expense was $4.0 in Q2, down from $10.2; for the first half, the company reported net interest income of $0.2 versus expense of $16.5, primarily reflecting gains on its interest-rate collar as rates rose.
Outlook, management commentary and risks
- Management expected to open at least 80 stores in fiscal 2022. It stated that cash on hand, operating cash flow and revolver availability should fund working capital, anticipated capital expenditures and obligations for the next 12 months and beyond.
- No quantified revenue or earnings guidance was provided in the supplied filing text. Management cautioned that seasonality and the uncertain macroeconomic environment make interim results an imperfect indicator of full-year performance.
- Management cited inflation and consumer uncertainty, COVID-19 and its variants, constrained exam capacity and shortages of vision-care professionals as factors affecting traffic, demand and costs. Recruitment, retention and remote-medicine initiatives were underway.
- The company raised its America’s Best signature offer price to $79.95 from $69.95 effective May 9, 2022, and its Eyeglass World opening offer to $89 from $78 effective March 14, 2022. Management said the changes were intended to preserve value propositions amid cost pressures.
- Interest-rate exposure remains: $150.0 of term-loan borrowings had a 2.9% weighted-average rate. The company said a 1% market-rate increase would not materially increase interest expense; a 1% decrease was estimated to increase derivative-related interest expense by about $5 million.
- After quarter-end, on July 19, the company extended its exclusive lens-supply agreement with Essilor by three years, through May 31, 2026. Walmart-related sales represented 7.7% of first-half consolidated revenue, presenting customer concentration risk.
- Legal matters arise in the ordinary course; the filing does not provide a clear quantified estimate of potential losses. Management reported disclosure controls were effective and no material changes in internal control over financial reporting.
Important facts for investors to verify
- Whether comparable-store sales, customer transactions and exam capacity improve, and whether the planned store openings are achieved.
- Whether lower eyeglass mix and margins, optometrist costs, wage and occupancy inflation, and impairment charges continue to pressure profitability.
- Whether operating cash flow recovers and capital spending, inventory and share repurchases remain consistent with liquidity and debt needs.
- Convertible-note terms and dilution exposure, variable-rate debt sensitivity, and continued compliance with credit covenants.
- Reliance on the Walmart relationship and the Essilor lens-supply agreement, including the effects of the agreement extension and any supply disruption.